KR870700638A - 임균의 주로 철-조절된 단백질과 이의 백신으로서의 용도 - Google Patents

임균의 주로 철-조절된 단백질과 이의 백신으로서의 용도

Info

Publication number
KR870700638A
KR870700638A KR870700423A KR870700423A KR870700638A KR 870700638 A KR870700638 A KR 870700638A KR 870700423 A KR870700423 A KR 870700423A KR 870700423 A KR870700423 A KR 870700423A KR 870700638 A KR870700638 A KR 870700638A
Authority
KR
South Korea
Prior art keywords
gonorrhea
vaccine
iron
mainly
regulated protein
Prior art date
Application number
KR870700423A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR870700638A publication Critical patent/KR870700638A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR870700423A 1985-10-24 1987-05-15 임균의 주로 철-조절된 단백질과 이의 백신으로서의 용도 KR870700638A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/790,910 US4681761A (en) 1985-10-24 1985-10-24 Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
PCT/US1986/002245 WO1987002678A1 (en) 1985-10-24 1986-10-24 Major iron-regulated protein of neisseria gonorrhoeae and its use as vaccine

Publications (1)

Publication Number Publication Date
KR870700638A true KR870700638A (ko) 1987-12-30

Family

ID=25152094

Family Applications (1)

Application Number Title Priority Date Filing Date
KR870700423A KR870700638A (ko) 1985-10-24 1987-05-15 임균의 주로 철-조절된 단백질과 이의 백신으로서의 용도

Country Status (6)

Country Link
US (1) US4681761A (ko)
EP (1) EP0245433A4 (ko)
JP (1) JPS63502427A (ko)
KR (1) KR870700638A (ko)
AU (1) AU594400B2 (ko)
WO (1) WO1987002678A1 (ko)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2202851B (en) * 1987-03-24 1990-12-19 Nat Res Dev Proteinaceous material of p. haemolytica and vaccine against pasteurella
AU609824B2 (en) * 1987-06-15 1991-05-09 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
US6348332B1 (en) 1987-11-24 2002-02-19 The University Of North Carolina At Chapel Hill DNA molecule encoding gonorrhoeal hybrid PIA/PIB protein
CA1340506C (en) * 1987-11-24 1999-04-20 Nicholas H. Carbonetti Production of gonorrheal pi proteins and vaccines
DE68918189T2 (de) * 1988-06-29 1995-01-12 Univ Rockefeller Neisseria-Vakzine.
DE68922888T2 (de) * 1988-10-07 1995-11-30 Eastman Kodak Co Verwendung eines kationischen Oberflächenaktivmittels zur Extraktion des Hauptprotein-Antigens der äusseren Membran von Chlamydia.
US5132205A (en) * 1988-10-07 1992-07-21 Eastman Kodak Company High ph extraction composition and its use to determine a chlamydial, gonococcal or herpes antigen
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
EP0444441B1 (en) * 1990-03-01 1996-09-25 Hewlett-Packard Company Minimizing eluate band widths in liquid chromatography
WO1992001460A1 (en) * 1990-07-16 1992-02-06 The University Of North Carolina Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins
ATE253114T1 (de) * 1990-08-23 2003-11-15 Univ North Carolina Transferrin bindende proteine aus neisseria- gonorrhoeae und neisseria-meningitidis
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
US5334503A (en) * 1991-10-08 1994-08-02 Eastman Kodak Company Test kit and method for the detection of microorganisms associated with periodontal diseases using surfactant mixture as extraction composition
JP2634545B2 (ja) * 1992-10-27 1997-07-30 日本全薬工業株式会社 Rtxトキシンファミリーに属する細菌毒素ワクチンの製造法
EP0749321B1 (en) 1994-02-09 2007-01-24 Epitopix LLC Active immunization using a siderophore receptor protein
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
GB9711964D0 (en) * 1997-06-09 1997-08-06 Medical Res Council Live attenuated vaccines
US6693186B2 (en) * 1998-09-01 2004-02-17 Antex Biologics Inc Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
US6756493B1 (en) 1998-09-01 2004-06-29 Antex Biologics, Inc. Nucleic acid sequence and uses thereof
GB0007432D0 (en) * 2000-03-27 2000-05-17 Microbiological Res Authority Proteins for use as carriers in conjugate vaccines
NZ526786A (en) * 2001-01-03 2006-02-24 Willmar Poultry Co Inc Methods for removal of lipopolysaccharides (LPS) from vaccines for non-human animals
NZ546601A (en) 2003-09-19 2010-07-30 Epitopix Llc Compositions comprising at least six isolated metal regulated polypeptides obtainable from campylobacter spp
US10166280B2 (en) 2016-06-08 2019-01-01 Epitopix, Llc Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3532790A (en) * 1968-02-23 1970-10-06 Canadian Patents Dev Somatic antigen vaccines from lysed inactivated bacteria and process for producing them
US3577527A (en) * 1969-01-27 1971-05-04 Us Navy Neisseria meningitidis antigen
US3855197A (en) * 1969-05-20 1974-12-17 Cassenne Lab Sa Glycoproteins extracted from microorganisms
US3636192A (en) * 1970-01-13 1972-01-18 Us Army Meningococcal polysaccharide vaccines
US3859434A (en) * 1973-01-08 1975-01-07 Canadian Patents Dev Meningococcal antigens
CA1045031A (en) * 1973-04-04 1978-12-26 Akzona Incorporated Serological test for gonorrheal antibodies
US4461838A (en) * 1975-04-25 1984-07-24 Bactex, Inc. Gonococcal Pili processes for the preparation thereof and the use thereof for the detection of and prevention of infections caused by Neisseria gonorrhoeae
US4029756A (en) * 1975-11-26 1977-06-14 Research Corporation Serological procedure for determining presence of neisseria gonorrhoeae antibodies
FR2374042A1 (fr) * 1976-06-04 1978-07-13 Merieux Inst Nouveau medicament immunostimulant et son procede de preparation
US4115543A (en) * 1976-12-20 1978-09-19 Canadian Patents & Development Limited Identification of Neisseria gonorrhoeae
US4123520A (en) * 1977-08-01 1978-10-31 Merck & Co., Inc. Method for preparing high molecular weight meningococcal Group C vaccine
US4134214A (en) * 1977-08-05 1979-01-16 Merck & Co., Inc. Freeze-drying process for the preparation of meningococcus vaccine without degradation of potency
US4203971A (en) * 1978-03-23 1980-05-20 Government Of The United States Neisseria gonorrhoeae vaccine
US4241045A (en) * 1978-05-15 1980-12-23 Research Corporation Purified antigen to test for Neisseria gonorrheae antibodies
US4351761A (en) * 1978-05-15 1982-09-28 Research Corporation Purified antigen to test for Neisseria gonorrhoeae antibodies
US4235994A (en) * 1978-06-26 1980-11-25 Merck & Co., Inc. High molecular weight meningococcal group C vaccine and method for preparation thereof
US4229530A (en) * 1978-08-29 1980-10-21 Board Of Regents, University Of Texas System Methods and media for rapid detection of pathogenic neisseria
US4220638A (en) * 1978-10-12 1980-09-02 Merck & Co., Inc. Antigenic complex from N. Gonorrhoeae
US4307080A (en) * 1979-09-24 1981-12-22 Merck & Co., Inc. Meningitis vaccine
US4239749A (en) * 1979-09-27 1980-12-16 United States Of America Neisseria gonorrhoeae vaccine
US4271147A (en) * 1980-01-10 1981-06-02 Behringwerke Aktiengesellschaft Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
US4443431A (en) * 1981-05-27 1984-04-17 The United States Of America As Represented By The Department Of Health And Human Services Neisseria gonorrhoeae vaccine
US4451446A (en) * 1982-03-04 1984-05-29 Smithkline-Rit Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
US4497900A (en) * 1982-04-12 1985-02-05 Abbott Laboratories Immunoassay for Neisseria gonorrhoeae antigens
US4459286A (en) * 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine

Also Published As

Publication number Publication date
WO1987002678A1 (en) 1987-05-07
EP0245433A4 (en) 1988-08-04
EP0245433A1 (en) 1987-11-19
JPS63502427A (ja) 1988-09-14
AU6623286A (en) 1987-05-19
US4681761A (en) 1987-07-21
AU594400B2 (en) 1990-03-08

Similar Documents

Publication Publication Date Title
KR870700638A (ko) 임균의 주로 철-조절된 단백질과 이의 백신으로서의 용도
FI103948B (fi) Kudoksen manipulointi ja ankkurointi
DK551187A (da) Terapeutisk praeparat og dettes fremstilling
DK543386A (da) Thienooxazinoner deres fremstilling og anvendelse
TR23668A (tr) Insan gövdesi akintisinin toplanmasi
FR2577139B1 (fr) Composition de vaccin et mode de sa preparation
TR22758A (tr) Yeni makroemuelsiyonlar bunlarin hazirlanisi icin usul ve zararhlarla muecadele de kullanimlari
DK62386D0 (da) Vaccine
KR880701524A (ko) 1-옥소히드로카르빌-치환 아자시클로헥산으로 되는 조성물 및 그의 용도
TR22145A (tr) Hidroksi-4-2h-1-benzotiopiron-2-one tuerevleri bunlarin hazirlanmasi ve kullanilmasi
DK205986D0 (da) Proteinhydrolysat samt fremstilling deraf
DK162686A (da) Pseudopterosin og syntetisk derivater deraf og forbindelsernes anvendelse
NO171242C (no) Fremgangsmaate for fremstilling av hudpleiepreparater med keratolytisk og antiinflammatorisk virkning
IT1214598B (it) Uso terapeutico della fosfocreatina.
DK24986A (da) Allergenholdige praeparater
TR24449A (tr) Tiyazinol tuerevleri hazirlanmalarina mahsus usul v ve fungusid olarak kullanimi
IT1217177B (it) Palmitoil-fruttosio-1,6-difosfato,suo uso terapeutico e relativi metodi di preparazione
NZ215576A (en) Antigenic protein of anaplasma marginale and vaccine
IT1222755B (it) Procedimento per la preparazione di idantoine 5-ariliden e alchiliden sostituite
SE8705060D0 (sv) Antiforkylningssats, antiforkylningspreparat och anvendning derav
DK478586D0 (da) Polyhydroxyalkyl-oligourinstoffer og deres anvendelse
DK66087D0 (da) Karbocykliske purinnukleosider og anvendelse og fremstilling deraf
IT8847653A0 (it) Sizzante comprendente 5 - idroscomposizione farmaceutica anoressitrpofano
DK567786D0 (da) Ikke-adjuvansholdig vaccine
DK195086D0 (da) Substituerede azolylmethylethere, deres fremstilling og anvendelse somfungicide midler

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application